Summary: The peel-away introducer by Abbott Medical is a device used for minimally invasive procedures, primarily in neurosurgery and pleuroscopy. Key evidence highlights its utility in reducing procedural trauma and facilitating access in complex anatomical areas.
The peel-away introducer received FDA clearance through the 510(k) pathway on March 1, 2023. It is manufactured by Abbott Medical and classified as a Class 2 device under product code DYB.
What It Is
The peel-away introducer is a medical device designed to facilitate the insertion of catheters or other instruments into the body with minimal trauma. It is commonly used in procedures requiring access to deep-seated anatomical structures, such as neurosurgical and pleural interventions.
Clinical Applications
This device is frequently used in neurosurgical procedures for accessing deep brain lesions and in pleuroscopy for managing pleural effusions. Its design allows for safe and efficient access in complex anatomical regions, reducing the need for larger incisions.
Evidence Summary
The literature includes 10 studies, comprising RCTs, prospective, retrospective, and case series designs, published between 2020 and 2025. These studies explore the device's application in various clinical settings, including neurosurgery and pleuroscopy.
Reported Outcomes
Published studies report that the peel-away introducer facilitates minimally invasive access to deep-seated lesions, reduces procedural trauma, and is cost-effective. It has been shown to be effective in enhancing the safety and efficiency of neurosurgical and pleural procedures.
Safety Profile
Reported complications include potential obstruction of the introducer by thrombus during procedures, which can be managed with alternative techniques. Overall, the device is associated with a low incidence of adverse events when used appropriately.
Evidence Limitations
Current evidence is limited by small sample sizes and the need for further large-scale studies to validate findings. There is also a need for more comprehensive data on long-term outcomes and safety across diverse patient populations.
Frequently Asked Questions
What are the clinical indications for the peel-away introducer?
The device is indicated for use in minimally invasive procedures requiring access to deep-seated anatomical structures, such as neurosurgery and pleuroscopy.
What outcomes have been reported in clinical studies?
Studies have reported that the device reduces procedural trauma and facilitates efficient access to complex anatomical areas, with positive outcomes in neurosurgical and pleural procedures.
What complications have been reported?
Safety data indicate potential complications such as thrombus obstruction during procedures, which can be managed with specific techniques. Overall, the device is associated with a low incidence of adverse events.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.
📬 Stay Updated
Get the latest vascular education content delivered to your inbox.